|
시장보고서
상품코드
2024423
위장용 스텐트 시장 보고서 : 제품 유형, 기술 유형, 소재, 최종사용자, 지역별(2026-2034년)Gastrointestinal Stents Market Report by Product Type, Technology Type, Material, End User, and Region 2026-2034 |
||||||
세계의 위장용 스텐트 시장 규모는 2025년에 4억 5,940만 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 5억 8,840만 달러에 달하며, 2026-2034년에 CAGR 2.70%로 성장할 것으로 예측하고 있습니다.
위장용 스텐트는 식도, 위, 소장의 막힘을 막기 위해 체내에 삽입하는 인공 관 모양의 이식편을 말합니다. 담관, 식도, 장, 결장 등의 해부학적 관강 내에 배치되는 확장 가능한 금속 또는 플라스틱 소재의 메쉬 튜브로, 암 조직에 의한 막힘을 제거하기 위한 목적으로 사용됩니다. 이를 통해 막힘을 제거하고 염증으로 인한 압력을 줄이는 것을 목표로 하고 있습니다. 가장 일반적인 위장용 스텐트 유형에는 담관용, 대장용, 십이지장용, 식도용, 췌장용 스텐트 등이 있습니다.
전 세계에서 대장암의 유병률이 증가하고 있는 것이 시장 성장을 이끄는 주요 요인 중 하나입니다. 또한 장 질환, 게실증, 소화기 악성 종양 등 소화기 질환을 앓고 있는 고령 인구의 증가도 시장 성장을 촉진하고 있습니다. 또한 저침습(MI) 수술에 대한 선호도 증가와 일반인들의 건강 의식 향상도 시장에 큰 영향을 미치고 있습니다. 기존의 개복 수술에 비해 소화관 스텐트 삽입술은 감염 위험이 낮고 출혈량이 적으며 회복 기간이 짧다는 특징이 있습니다. 또한 높은 유연성과 굴곡 저항성을 갖춘 생체흡수성 스텐트 및 니티놀 소재 기반 스텐트 개발 등 다양한 기술 발전도 시장 성장을 촉진하는 요인으로 작용하고 있습니다. 이 외에도 의료 인프라의 획기적인 개선, 정부의 지원책 시행, 광범위한 연구개발(R&D) 활동 등이 시장을 더욱 견인할 것으로 예상됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 위장용 스텐트 시장
제6장 시장 내역 : 제품 유형별
제7장 시장 내역 : 기술 유형별
제8장 시장 내역 : 소재별
제9장 시장 내역 : 최종사용자별
제10장 시장 내역 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porters Five Forces 분석
제14장 가격 지표
제15장 경쟁 구도
KSA 26.05.14The global gastrointestinal stents market size reached USD 459.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 588.4 Million by 2034, exhibiting a growth rate (CAGR) of 2.70% during 2026-2034.
A gastrointestinal stent refers to an artificial tube graft that is inserted in the body to prevent blockages in the gullet, stomach and small intestine. It is an expandable metal or a plastic mesh tube that is placed in an anatomical duct, such as bile ducts, esophagus, bowel or colon, and blockages due to cancerous tissues. It aims to remove the obstruction and reduce the pressure caused by inflammation. Some of the most common types of gastrointestinal stents include biliary, colonic, duodenal, esophageal and pancreatic stents.
The rising prevalence of colorectal cancer across the globe is one of the key factors driving the growth of the market. Furthermore, an increasing geriatric population suffering from gastrointestinal diseases, such as bowel ailments, diverticulosis and gastrointestinal malignancies, is also providing a boost to the market growth. Additionally, the growing preference for minimally invasive (MI) surgical procedures, along with the rising health consciousness among the masses, is creating a significant impact on the market. In comparison to the traditional open surgery procedures, gastrointestinal stenting involves low risk of infections, minimal loss of blood and quick recuperation period. Moreover, various technological advancements, including the development of bio-absorbable and nitinol material-based stents offering a high degree of flexibility and kink-resistance, is acting as another growth-inducing factor. Other factors, including significant growth in the healthcare infrastructure, the implementation of favourable government policies and extensive research and development (R&D) activities, are projected to drive the market further.
KEY MARKET SEGMENTATION :
Breakup by Product Type:
- Biliary Stents
- Duodenal Stents
- Colonic Stents
- Pancreatic Stents
- Esophageal Stents
Breakup by Technology Type:
- Anti-Migratory Stents
- Drug-Eluting Stents
- Radioactive Stents
- Anti-Reflux Stents
- Shape-Modified Stents
- Others
Breakup by Material:
- Plastic Stents
- Self-Expanding Metal Stents
- Stainless Steel Stents
- Nitinol Stents
- Others
- Covered Self-Expandable Metallic Stents
- Biodegradable or Drug Eluting Stents
Breakup by End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centres
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report provides a comprehensive analysis of the competitive landscape in the global gastrointestinal stents market with detailed profiles of all major companies, including:
- Becton, Dickinson and Company
- Boston Scientific Corporation
- Cantel Medical Corporation
- CONMED Corporation
- Cook Medical
- ELLA-CS, s.r.o.
- Hobbs Medical, Inc.
- Medline Industries, LP
- Medtronic plc
- Merit Medical Systems Inc.
- Olympus Corporation
- W. L. Gore & Associates, Inc.
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Gastrointestinal Stents Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Biliary Stents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Duodenal Stents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Colonic Stents
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Pancreatic Stents
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Esophageal Stents
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Technology Type
- 7.1 Anti-Migratory Stents
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Drug-Eluting Stents
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Radioactive Stents
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Anti-Reflux Stents
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Shape-Modified Stents
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Material
- 8.1 Plastic Stents
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Self-Expanding Metal Stents
- 8.2.1 Market Trends
- 8.2.2 Major Types
- 8.2.2.1 Stainless Steel Stents
- 8.2.2.2 Nitinol Stents
- 8.2.2.3 Others
- 8.2.3 Market Forecast
- 8.3 Covered Self-Expandable Metallic Stents
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Biodegradable or Drug Eluting Stents
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Specialty Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Ambulatory Surgical Centres
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Becton, Dickinson and Company
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Boston Scientific Corporation
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Cantel Medical Corporation
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 CONMED Corporation
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Cook Medical
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 ELLA-CS, s.r.o.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Hobbs Medical, Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Medline Industries, LP
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Medtronic plc
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Merit Medical Systems Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Olympus Corporation
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 W. L. Gore & Associates, Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.1 Becton, Dickinson and Company
